Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

First Data On Direct Costs of Lung Cancer Management in Morocco

  • Tachfouti, N. (Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine) ;
  • Belkacemi, Y. (AP-HP CHU Henri Mondor and Paris XII University, Association of Radiotherapy and Oncology of the Mediterranean Area) ;
  • Raherison, C. (Public Health, Epidemiology and Development Institute) ;
  • Bekkali, R. (Lalla Salma Association Against Cancer) ;
  • Benider, A. (Oncology Department, University Teaching Hospital Ibn Rochd) ;
  • Nejjari, C. (Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine)
  • Published : 2012.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Lung cancer is the leading cause of cancer morbidity and mortality. Its management has a significant economic impact on society. Despite a high incidence of cancer, so far, there is no national register for this disease in Morocco. The main goal of this report was to estimate the medical costs of lung cancer in our country. Methods: We first estimated the number of annual new cases according to stage of the disease on the basis of the Grand-Casablanca-Region Cancer Registry data. For each sub-group, the protocol of treatment was described taking into account the international guidelines, and an evaluation of individual costs during the first year following diagnosis was made. Extrapolation of the results to the whole country was used to calculate the total annual cost of treatments for lung cancer in Morocco. Results: Overall approximately 3,500 new cases of lung cancer occur each year in the country. Stages I and II account for only 4% of cases, while 96% are diagnosed at locally advanced or metastatic stages III and IV. The total medical cost of lung cancer in Morocco is estimated to be around USD 12 million. This cost represents approximately 1% of the global budget of the Health Department. According to AROME Guidelines, about 86% of the newly diagnosed lung cancer cases needed palliative treatment while 14% required curative intent therapy. The total cost of early and advanced stages lung cancer management during the first year were estimated to be 4,600 and 3,420 USD, respectively. Conclusion: This study provides health decision-makers with a first estimate of costs and the opportunity to achieve the optimal use of available data to estimate the needs of health facilities in Morocco. A substantial proportion of the burden of lung cancer could be prevented through the application of existing cancer control knowledge and by implementing tobacco control programs.

Keywords

References

  1. AROME (2011). Guidelines, minimal requirements and standard of cancer care around the Mediterranean Area: Report from the Collaborative AROME (Association of Radiotherapy and Oncology of the Mediterranean Area). Crit Rev Oncol/Hematol, 78, 1-16. https://doi.org/10.1016/j.critrevonc.2010.03.007
  2. Bray FI, Weiderpass E (2010). Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970-2007. Int J Cancer, 126, 1454-66.
  3. Centers for Disease Control and Prevention (2007). Best Practices for Comprehensive Tobacco Control Programs-2007. Atlanta, GA: US Department of Health and Human Services. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2007.
  4. Crowell RE, Goetz T, Wiggins C, et al (2007). Regional disparities in treatment and survival of early stage non-small cell lung cancer. Ethn Dis, 17, 358-64.
  5. Demeter SJ, Jacobs P, Chmielowiec C, et al (2007). The cost of lung cancer in Alberta. Can Respir J, 14,81-6.
  6. Esnaola NF, Lazarides SN, Mentzer SJ, et al (2002). Outcomes and cost-effectiveness of alternate staging strategies for nonsmall- cell lung cancer. J Clin Oncol, 20, 263-73. https://doi.org/10.1200/JCO.20.1.263
  7. Ezzati M, Henley SJ, Lopez AD, et al (2005). Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer, 116, 963-71. https://doi.org/10.1002/ijc.21100
  8. Ferlay J, Bray F, Pisani P, et al (2001). Globocan 2000: cancer incidence, mortality and prevalence worldwide, version 1.0.IARC Cancer Base No 5. Lyon: IARC Press.
  9. Huxley R, Jamrozik K, Lam TH, et al (2007). Impact of smoking and smoking cessation on lung cancer mortality in the Asia Pacific region. Am J Epidemiol, 165, 1280-6. https://doi.org/10.1093/aje/kwm002
  10. Jemal A, Bray F, Melissa M, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  11. Macbeth FR, Abratt RP, Cho KH, et al (2007). Lung cancer management in limited resource settings: guidelines for appropriate good care. Radiother Oncol, 82,123-31. https://doi.org/10.1016/j.radonc.2006.12.006
  12. Mackay J, Eriksen M, Shafey O (2006). The Tobacco Atlas. 2nd ed. Atlanta, GA: American Cancer Society.
  13. McCarthy M, Datta P, Khachatryan A, et al (2008). Would compliance with cancer care standards improve survival for breast, colorectal and lung cancers? J Epidemiol Community Health, 62, 650-4. https://doi.org/10.1136/jech.2007.066258
  14. National Institute for Health Clinical Excellence (2007). The guidelines man- ual. London: National Institute for Health and Clinical Excellence.
  15. Nejjari C, Benjelloun MC, Berraho M, et al (2009). Prevalence and demographic factors of smoking in Morocco. Int J Public Health, 54, 447-51. https://doi.org/10.1007/s00038-009-0082-2
  16. Oliver E, Killen J, Kiebert G, et al (2001). Treatment pathways, resource use and costs in the management of small cell lung cancer. Thorax, 56, 785-90. https://doi.org/10.1136/thorax.56.10.785
  17. Ou SH, Ziogas A, Zell JA (2009). Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity. J Thorac Oncol, 4, 37-43. https://doi.org/10.1097/JTO.0b013e31819140fb
  18. Parkin DM (2001). Global cancer statistics in the year 2000. Lancet Oncol, 2, 533-43. https://doi.org/10.1016/S1470-2045(01)00486-7
  19. Parkin DM, Pisani P, Ferlay J (1999). Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 80, 827-41. https://doi.org/10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P
  20. Pentheroudakis G, Stahel R, Hansen H, et al (2008). Heterogeneity in cancer guidelines: should we eradicate or tolerate? Ann Oncol, 19, 2067-78. https://doi.org/10.1093/annonc/mdn418
  21. Rawaf S, Dubois E, Khatib OM et al (2006). Cancer prevention and control in. Eastern Mediterranean region. BMJ, 333, 860-1.
  22. Registry of tumors in Great Casablanca region (2004). Annual Report. Casablanca.
  23. Shafey O, Eriksen M, Ross H, et al (2009). The Tobacco Atlas. 3rd ed. Atlanta, GA:American Cancer Society.
  24. Smith TJ, Hilnner BE (2001). Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol, 19, 2886-97.
  25. Tazi MA, Abid-Khalil S, Chaouki N (2003). La prevalence des facteurs de risque cardiovasculaires au Maroc : resultats d'une étude nationale 2000. J Hypertens, 21, 897-903. https://doi.org/10.1097/00004872-200305000-00013
  26. Vergnenegre A, Molinier L, Chouaid C (2001). Economic analyses and lung cancer. Monaldi Arch Chest Dis, 56, 336-43.
  27. Youlden DR, Cramb SM, Baade PD (2008). The International Epidemiology of Lung Cancer:geographical distribution and secular trends. J Thorac Oncol, 3, 819-831. https://doi.org/10.1097/JTO.0b013e31818020eb

Cited by

  1. Costs During the First Five Years Following Cancer Diagnosis in Korea vol.13, pp.8, 2012, https://doi.org/10.7314/APJCP.2012.13.8.3767
  2. Staging with PET-CT in Patients with Locally Advanced Non Small Cell Lung Cancer is Superior to Conventional Staging Methods in Terms of Survival vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3743
  3. The Economic Burden of Cancer in Korea in 2009 vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1295
  4. Cost of Pediatric Visceral Leishmaniasis Care in Morocco vol.11, pp.6, 2016, https://doi.org/10.1371/journal.pone.0155482
  5. Estimated costs of advanced lung cancer care in a public reference hospital vol.51, pp.0, 2017, https://doi.org/10.1590/s1518-8787.2017051006665
  6. The prevalence of chronic pain in developing countries vol.3, pp.2, 2013, https://doi.org/10.2217/pmt.12.83